Press release: CTi is based in Connecticut, USA and was founded in 1990 to cater for the growing demand for high quality translation services in the life sciences sector. It is now a recognised leader in successfully managing complex translation projects on behalf of the world’s top pharmaceutical and biotech companies and their Clinical Research Organisation (CRO) partners. As CTi’s customers operate in highly regulated and audited industries, they place a premium on high quality translations being delivered to specific deadlines. CTi enjoys a preferred supplier relationship with many of its key customers, with extraordinary penetration of the blue chip life science community. The acquisition is in line with the strategy of complementing organic growth with selective acquisition.
B2B B2C Exhibitions Events Digital Publishing MarComms